InvestorsHub Logo
Followers 138
Posts 23065
Boards Moderated 0
Alias Born 04/08/2004

Re: georgejjl post# 176105

Wednesday, 03/22/2017 11:02:11 PM

Wednesday, March 22, 2017 11:02:11 PM

Post# of 402976

...Brilacidin has dual functionality in not only shortening the duration and intensity of OM in patients with head and neck cancers, but also preventing the onset of the condition, an accomplishment no other pharmaceutical company has achieved.



o Upcoming Milestone: Interim analysis of the Phase 2 trial is expected in approximately 6 to 8 weeks.

http://www.cellceutix.com/press-release/2017/2/15/y3616250ilexnq8enkoy8lelciljue

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News